<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
<url>
  <loc>https://www.finanzwire.com/article/sanofis-vaccine-shows-superior-tolerability-in-recent-study-TfYQdozAify</loc>
  <lastmod>2026-04-18T10:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T10:05:00.000Z</news:publication_date>
    <news:title>Sanofi&apos;s Vaccine Shows Superior Tolerability in Recent Study</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>COVID-19,Sanofi,Nuvaxovid,Vaccine Study,Tolerability</news:keywords>
    <news:stock_tickers>EPA:SAN</news:stock_tickers>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/sanofis-nuvaxovid-demonstrates-better-tolerability-compared-to-mnexspike-Ic3n9MfeJCj</loc>
  <lastmod>2026-04-18T10:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T10:05:00.000Z</news:publication_date>
    <news:title>Sanofi&apos;s Nuvaxovid demonstrates better tolerability compared to mNEXSPIKE</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Sanofi,Tolérance,Nuvaxovid,ESCMID,COVID-19 Vaccination</news:keywords>
    <news:stock_tickers>EPA:SAN</news:stock_tickers>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/press-release-escmid-sanofis-nuvaxovid-covid-19-vaccine-showed-better-tolerability-than-mnexspike-in-head-to-head-study-maJJhtVEoL9</loc>
  <lastmod>2026-04-18T10:00:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T10:00:00.000Z</news:publication_date>
    <news:title>Press Release: ESCMID: Sanofi&apos;s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>COVID-19,Sanofi,Vaccine,Nuvaxovid,Tolerability</news:keywords>
    <news:stock_tickers>EPA:SAN</news:stock_tickers>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/formation-metals-addresses-promotional-activity-concerns-ODwh4X1V54j</loc>
  <lastmod>2026-04-18T02:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T02:05:00.000Z</news:publication_date>
    <news:title>Formation Metals Addresses Promotional Activity Concerns</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Investor Relations,OTC Markets,Trading Volume,Formation Metals,Promotional Activity</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/formation-metals-responds-to-otc-markets-request-on-recent-promotional-activity-yQeOiOlJEOk</loc>
  <lastmod>2026-04-18T02:00:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T02:00:00.000Z</news:publication_date>
    <news:title>Formation Metals Responds to OTC Markets Request on Recent Promotional Activity</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>Investor Relations,OTC Markets,Formation Metals Inc.,Promotional Activity,Third-party Marketing Firms</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/aiml-innovations-completes-share-issuance-M8TMop5eSJ8</loc>
  <lastmod>2026-04-18T00:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T00:05:00.000Z</news:publication_date>
    <news:title>AI/ML Innovations Completes Share Issuance</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Debt Settlement,Related Party Transaction,AI/ML Innovations,Share Issuance,Securities Regulation</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/aiml-innovations-announces-completion-of-share-issuance-WRC0RFgbs25</loc>
  <lastmod>2026-04-18T00:00:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-18T00:00:00.000Z</news:publication_date>
    <news:title>AI/ML Innovations Announces Completion of Share Issuance</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>AI/ML Innovations Inc.,Share Issuance,Insiders,Debt,Statutory Hold Period</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/medicure-announces-leadership-change-bDbjIuVMnGc</loc>
  <lastmod>2026-04-17T23:40:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T23:40:00.000Z</news:publication_date>
    <news:title>Medicure Announces Leadership Change</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Pharmaceuticals,Strategic Priorities,Medicure Inc.,Leadership Change,United States Market</news:keywords>
    <news:stock_tickers>NASDAQ:MCUJF</news:stock_tickers>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/medicure-announces-resignation-of-president-and-chief-operating-officer-Xd0LFVklBV2</loc>
  <lastmod>2026-04-17T23:35:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T23:35:00.000Z</news:publication_date>
    <news:title>Medicure Announces Resignation of President and Chief Operating Officer</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>Pharmaceuticals,Resignation,Healthcare,Medicure Inc.,Leadership</news:keywords>
    <news:stock_tickers>NASDAQ:MCUJF</news:stock_tickers>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/onco-innovations-enhances-leadership-with-key-appointments-610ITz10JB2</loc>
  <lastmod>2026-04-17T23:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T23:05:00.000Z</news:publication_date>
    <news:title>Onco-Innovations Enhances Leadership with Key Appointments</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Clinical Trials,Executive Appointments,Oncology Development,Research Strategy,Leadership In Biotechnology</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/onco-innovations-strengthens-executive-leadership-with-appointment-of-dr-islam-mohamed-as-chief-medical-officer-and-stephen-m-novak-as-chief-of-research-and-development-txxB3Tx9Y0i</loc>
  <lastmod>2026-04-17T23:00:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T23:00:00.000Z</news:publication_date>
    <news:title>Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>Appointment,Clinical Development,R&amp;D,Onco-Innovations,ONC010</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/maternal-rsv-vaccination-significantly-reduces-infant-hospitalisation-risk-NlfrkThkClD</loc>
  <lastmod>2026-04-17T22:10:22.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T22:10:22.000Z</news:publication_date>
    <news:title>Maternal RSV Vaccination Significantly Reduces Infant Hospitalisation Risk</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Maternal Health,RSV Vaccination,Infant Hospitalisation,UKHSA Study,Preterm Infants</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/escmid-global-maternal-rsv-vaccination-cuts-infant-hospitalisation-risk-by-over-80-major-ukhsa-study-finds-sVlumVc0wCL</loc>
  <lastmod>2026-04-17T22:05:22.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T22:05:22.000Z</news:publication_date>
    <news:title>ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>ESCMID Global 2026,UKHSA Study,Maternal RSV Vaccination,Infant Hospitalization Risk,RSV Impact On Infants</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/redwood-ai-partners-with-aidos-innovations-to-combat-fentanyl-crisis-in-bc-WGdi46ZH7nR</loc>
  <lastmod>2026-04-17T22:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T22:05:00.000Z</news:publication_date>
    <news:title>Redwood AI Partners with Aidos Innovations to Combat Fentanyl Crisis in B.C.</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Public Safety,Redwood AI,Aidos Innovations,Fentanyl Crisis,Track And Trace</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/redwood-ai-announces-collaboration-with-aidos-innovations-aimed-at-enhancing-public-safety-collaboration-with-bc-government-canadian-federal-and-local-law-enforcement-agencies-to-tackle-the-fentanyl-crisis-in-british-columbia-E0FmciFHWga</loc>
  <lastmod>2026-04-17T22:00:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T22:00:00.000Z</news:publication_date>
    <news:title>Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>Opioid Crisis,Redwood AI,AI Initiative,Aidos Innovations,Track And Trace</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/rektron-group-inc-appoints-new-director-vR7XvS56sZW</loc>
  <lastmod>2026-04-17T21:42:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T21:42:00.000Z</news:publication_date>
    <news:title>Rektron Group Inc. Appoints New Director</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Sustainable Operations,Global Energy Transition,Commodities Trading,Rektron Group,Richard Elliot-Square</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/rektron-group-inc-announces-appointment-of-a-new-director-qbxJuBwcPSS</loc>
  <lastmod>2026-04-17T21:37:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T21:37:00.000Z</news:publication_date>
    <news:title>Rektron Group Inc. Announces Appointment of a New Director</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>Global Markets,Sustainable Supply Chain,Commodity Trading,Rektron Group Inc.,Richard Elliot-Square</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/aip-realty-trust-completes-third-tranche-of-preferred-units-offering-KZhxSH1mhOW</loc>
  <lastmod>2026-04-17T21:05:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T21:05:00.000Z</news:publication_date>
    <news:title>AIP Realty Trust Completes Third Tranche of Preferred Units Offering</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Private Placement,Investment Funding,AIP Realty Trust,Preferred Units,AllTrades Transaction</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/press-release/aip-realty-trust-closes-third-tranche-of-non-brokered-offering-of-preferred-units-NdhpAJoKdr6</loc>
  <lastmod>2026-04-17T21:00:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T21:00:00.000Z</news:publication_date>
    <news:title>AIP Realty Trust Closes Third Tranche of Non-Brokered Offering of Preferred Units</news:title>
    <news:genres>PressRelease</news:genres>
    <news:keywords>Private Placement,AIP Realty Trust,Preferred Units,AllTrades Transaction,Series B Convertible</news:keywords>
  </news:news>
</url>
<url>
  <loc>https://www.finanzwire.com/article/vulcan-minerals-inc-grants-stock-options-yexCOi23kHm</loc>
  <lastmod>2026-04-17T20:35:00.000Z</lastmod>
  <changefreq>daily</changefreq>
  <priority>0.8</priority>
  <news:news>
    <news:publication>
      <news:name>Finanzwire</news:name>
      <news:language>en</news:language>
    </news:publication>
    <news:publication_date>2026-04-17T20:35:00.000Z</news:publication_date>
    <news:title>Vulcan Minerals Inc. Grants Stock Options</news:title>
    <news:genres>Blog</news:genres>
    <news:keywords>Stock Options,TSX Venture Exchange,Exploration Company,Atlas Salt,Vulcan Minerals</news:keywords>
  </news:news>
</url>
</urlset>